Effects of cannabis and psychosis vulnerability in daily life: An experience sampling test study

Psychological Medicine

Volumn 33, Issue 1, 2003, Pages 23-32

  Verdoux, Hélène ^a   Gindre, C ^a   Sorbara, F ^a   Tournier, M ^a   Swendsen, J D ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; COCAINE; PSYCHOSTIMULANT AGENT;

ADULT; ARTICLE; CANNABIS ADDICTION; COLLEGE STUDENT; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXPERIENCE; FEMALE; HUMAN; INTERVIEW; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PERCEPTION; PSYCHOSIS; PUBLIC HEALTH; RISK FACTOR; SELF MEDICATION; SYMPTOMATOLOGY; THOUGHT DISORDER;

ADULT; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MARIJUANA ABUSE; PSYCHOTIC DISORDERS; RISK FACTORS; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; STUDENTS;

EID: 0037237704     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291702006384     Document Type: Article

References (50)

1. Addington, J. & Addington, D. (1998). Effect of substance misuse in early psychosis. British Journal of Psychiatry 172 (Suppl. 33), 134-136.
2. Amorin, P., Lecrubier, Y., Weiller, E., Hergueta, T. & Sheehan, D. (1998). DSM-III-R psychotic disorders: procedural validity of the MINI International Neuropsychiatric, Interview (MINI). Concordance and causes for discordance with the CIDI. European Psychiatry 13, 26-34.
3. Andreasson, S., Allebeck, P., Engstrom, A. & Rydberg, U. (1987). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts, Lancet ii, 1483-1486.
4. Ashton, C. (2001). Pharmacology and effects of cannabis: a brief review. British Journal of Psychiatry 178, 101-106.
5. Clayton, D. & Hills, M. (1993). Testing hypotheses. In Statistical Models in Epidemiology (ed. D. Clayton and M. Hills), pp. 237-248. Oxford University Press: Oxford.
6. Dean, B., Sundram, S., Bradbury, R., Scarr, E. & Copolov, D. (2001). Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 103, 9-15.
7. Degenhardt, L. & Hall, W. (2001). The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychological Medicine 31, 659-668.
8. Delespaul, P. (1995). Assessing Schizophrenia in Daily Life. Maastricht University Press: Maastricht.
9. Eaton, W., Romanoski, A., Anthony, J. C. & Nestadt, G. (1991). Screening for psychosis in the general population with a self-report interview. Journal of Nervous and Mental Disease 179, 689-693.
10. Golstein, H. (1987). Multilevel Models in Educational and Social Research. Griffin: London.
11. Hall, W. & Solowij, N. (1997). Long-term cannabis use and mental health. British Journal of Psychiatry 171, 107-108.
12. Hambrecht, M. & Hafner, H. (1996). Substance abuse and the onset of schizophrenia. Biological Psychiatry 40, 1155-1163.
13. Johns, A. (2001). Psychiatric effects of cannabis. British Journal of Psychiatry 178, 116-122.
14. Kibel, D. A., Laffont, I. & Liddle, P. F. (1993). The composition of the negative syndrome of chronic schizophrenia. British Journal of Psychiatry 162, 744-750.
15. Kovasznay, B., Fleischer, J., Tanenberg-Karant, M., Jandorf, L., Miller, A. D. & Bromet, E. (1997). Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophrenia Bulletin 23, 195-201.
16. Lecrubier, Y., Seehan, D., Weiller, E., Amorin, P., Bonora, I., Seehan, K., Janavs, J. & Dunbar, G. C. (1997). The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry 12, 224-231.
17. Linszen, D. H., Dingemans, P. & Lernior, M. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 51, 273-279.
18. McGuire, P. & Fahy, T. (1991). Chronic paranoid psychosis after misuse of MDMA ('ecstasy'). British Medical Journal 302, 697.
19. McGuire, P. K., Cope, H. & Fahy, T. A. (1994). Diversity of psychopathology associated with use of 3, 4-methylenedioxymethamphetamine (' Ecstasy'). British Journal of Psychiatry 165, 391-395.
20. McGuire, P. K., Jones, P., Harvey, I., Williams, M., McGuffin, P. & Murray, R. M. (1995). Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophrenia Research 15, 277-281.
21. Myin-Germeys, I., Delespaul, P. & de Vries, M. (2001). The context of delusional experiences in the daily life of patients with schizophrenia. Psychological Medicine 31, 489-498.
22. Perkonigg, A., Lieb, R., Hofler, M., Schuster, P., Sonntag, H. & Wittchen, H. (1999). Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents. Addiction 94, 1663-1678.
23. Peters, E. R., Joseph, S. A. & Garety, P. A. (1999). Measurement of delusional ideation in the normal population: introducing the PDI (Peters et al. Delusions Inventory). Schizophrenia Bulletin 25, 553-576.
24. Poole, R. G. & Brabbins, C. J. (1996). Drug induced psychosis. British Journal of Psychiatry 168, 135-138.
25. Poulton, R., Caspi, A., Moffitt, T., Cannon, M., Murray, R. & Harrington, H. (2000). Children's self-reported psychotic symptoms and adult schizophreniform disorder. Archives of General Psychiatry 57, 1053-1058.
26. Rabinowitz, J., Bromet, E., Lavelle, J., Carlson, G., Kovasznay, B. & Schwartz, J. E. (1999). Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychological Medicine 28, 1411-1419.
27. Regier, D., Farmer, M., Rae, D., Locke, B., Keith, S., Judd, L. & Goodwin, F. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Journal of the American Medical Association 264, 2511-2518.
28. Rose, G. (1992). The Strategy of Preventive Medicine. Oxford University Press: Oxford.
29. Selten, J. P., Gernaat, H. B., Nolen, W. A., Wiersma, D. & van den Bosch, R. J. (1998). Experience of negative symptoms: comparison of schizophrenic patients to patients with a depressive disorder and to normal subjects. American Journal of Psychiatry 155, 350-354.
30. Shiffman, S. & Prange, M. (1988). Self-reported and self-monitored smoking patterns. Addictive Behavior 13, 201-204.
31. Skosnik, P. D., Spatz-Glenn, L. & Park, S. (2001). Cannabis use is associated with schizotypy and attentional disinhibition. Schizophrenia Research 48, 83-92.
32. Smart, R. & Ogborne, A. (2000). Drug use and drinking among students in 36 countries. Addictive Behavior 25, 455-460.
33. StataCorp (2001). Stata Statistical Software: Release 7.0. STATA Corporation: College Station, TX.
34. Stefanis, N., Hanssen, M., Smyrnis, N., Avramopoulos, D., Evdokimidis, I., Verdoux, H. & van Os, J. (2001). Evidence that three dimensions of psychosis have a distribution in the general population. Psychological Medicine 32, 347-358.
35. Swendsen, J. D. & Norman, S. (1998). Preparing for community violence: mood and behavioral correlates of the second Rodney King verdicts. Journal of Trauma Stress 11, 57-70.
36. Swendsen, J. D., Tennen, H., Carney, M. A., Affleck, G., Willard, A. & Hromi, A. (2000). Mood and alcohol consumption: an experience sampling test of the self-medication hypothesis. Journal of Abnormal Psychology 109, 198-204.
37. 1 opoid receptor mechanism. Science 276, 2048-2050.
38. Vaiva, G., Boss, V., Bailly, D., Thomas, P., Lestavel, P. & Goudemand, M. (2001). An 'accidental' acute psychosis with ecstasy use. Journal of Psychoactive Drugs 33, 95-98.
39. Van Os, J., Hanssen, M., Bijl, R. & Ravelli, A. (2000). Strauss (1969) revisited: a psychosis continuum in the general population? Schizophrenia Research 45, 11-20.
40. Van Os, J., Hanssen, M., Bijl, R. & Vollebergh, W. (2001). Prevalence of psychotic disorder and community level of psychotic symptoms. Archives of General Psychiatry 58, 663-668.
41. Van Os, J., Bak, M., Hanssen, M., Bijl, R. V., de Graaf, R. & Verdoux, H. (2002). Cannabis and psychosis: a longitudinal population-based study. American Journal of Epidemiology 156, 319-327.
42. Verdoux, H., Maurice-Tison, S., Gay, B., van Os, J., Salamon, R. & Bourgeois, M. (1998 a). A survey of delusional ideation in primary care patients. Psychological Medicine 28, 127-134.
43. Verdoux, H., van Os, J., Maurice-Tison, S., Gay, B., Salamon, R. & Bourgeois, M. (1998b). Is early adulthood a critical developmental stage for psychosis proneness? A survey of delusional ideation in normal subjects. Schizophrenia Research 29, 247-254.
44. Verdoux, H., Liraud, F., Gonzales, B., Assens, F., Abalan, F. & van Os, J. (1999a). Suicidality and substance misuse in first-admitted subjects with psychotic disorder. Acta Psychiatrica Scandinavica 100, 389-395.
45. Verdoux, H., van Os, J., Maurice-Tison, S., Gay, B., Salamon, R. & Bourgeois, M. (1999b). Increased occurrence of depression in psychosis-prone subjects. A follow-up study in primary care settings. Comprehensive Psychiatry 40, 462-468.
46. Verdoux, H., Sorbara, F., Gindre, C., Swendsen, J. & Van Os, J. (2002). Cannabis use and dimensions of psychosis in a non-clinical population of female subjects. Schizophrenia Research (in the press).
47. Webb, E., Ashton, C., Kelly, P. & Kamali, F. (1996). Alcohol and drug use in UK university students. Lancet 348, 922-925.
48. Weiser, M., Reichenberg, A., Rabinowitz, J., Kaplan, Z., Caspi, A., Yasvizky, R., Mordechai, M., Nahon, D. & Davidson, M. (2002). Self-reported drug abuse in male adolescents with behavioural disturbances, and follow-up for future schizophrenia. Schizophrenia Research 53 (Suppl.), 227.
49. Williams, J. H., Wellman, N. A. & Rawlins, J. N. (1996). Cannabis use correlates with schizotypy in healthy people. Addiction 91, 869-877.
50. Yung, A. R., Phillips, L. J., McGorry, P. D., McFarlane, C. A., Francey, S., Harrigan, S., Patton, G. C. & Jackson, H. J. (1998). Prediction of psychosis. A step towards indicated prevention of schizophrenia. British Journal of Psychiatry 172, 14-20.